|
AFG3L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.39209763108761E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.21279994327972E-10 |
| Normal-vs-Stage2 |
5.638100E-03 |
| Normal-vs-Stage3 |
2.063100E-03 |
| Normal-vs-Stage4 |
1.90820004242198E-09 |
| Stage1-vs-Stage2 |
6.567800E-01 |
| Stage1-vs-Stage3 |
8.224000E-01 |
| Stage1-vs-Stage4 |
3.034000E-02 |
| Stage2-vs-Stage3 |
8.543200E-01 |
| Stage2-vs-Stage4 |
6.112100E-02 |
| Stage3-vs-Stage4 |
8.836100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.58350008053299E-10 |
| Normal-vs-AfricanAmerican |
9.95400000203261E-08 |
| Normal-vs-Asian |
1.141800E-01 |
| Caucasian-vs-AfricanAmerican |
7.377200E-01 |
| Caucasian-vs-Asian |
6.227400E-01 |
| AfricanAmerican-vs-Asian |
6.858000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60950150376971E-11 |
| Normal-vs-Female |
4.2186000004385E-07 |
| Male-vs-Female |
5.130400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.61800000000523E-05 |
| Normal-vs-Extreme_Weight |
3.50359741219108E-11 |
| Normal-vs-Obese |
2.01259999998982E-07 |
| Normal-vs-Extreme_Obese |
8.961600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.447200E-01 |
| Normal_Weight-vs-Obese |
7.825600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.232000E-01 |
| Extreme_Weight-vs-Obese |
4.830000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.326170E-01 |
| Obese-vs-Extreme_Obese |
1.864570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.002900E-04 |
| Normal-vs-Age(41-60Yrs) |
7.55130402652071E-11 |
| Normal-vs-Age(61-80Yrs) |
1.32680000319851E-08 |
| Normal-vs-Age(81-100Yrs) |
4.834300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.876200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.415400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.626600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.702200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.048200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.773400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64424029946986E-13 |
| Normal-VS-Type2 PRCC |
1.628350E-02 |
| Normal-VS-KIRP CIMP |
3.27689986256985E-10 |
| Normal-VS-Unclassified PRCC |
2.42359999998998E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.421300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.197500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.508600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.760200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.080400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.812200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.96539999999901E-06 |
| Normal-vs-N1 |
6.366800E-04 |
| Normal-vs-N2 |
1.16660000004654E-06 |
| N0-vs-N1 |
5.550000E-01 |
| N0-vs-N2 |
1.440000E-01 |
| N1-vs-N2 |
3.267600E-01 |
|
|
